(Reuters) – Europe’s medicines regulator gave the go ahead on Friday for an extra sixth dose to be extracted from the Pfizer-BioNTech COVID-19 vaccine vials, lifting the number of available shots at a time when supplies are short.
EU countries started inoculating people with the Pfizer-BioNTech vaccine two weeks ago, after the European Medicines Agency (EMA) recommended the shot’s conditional approval under an authorisation which allows five doses to be extracted from each vial.
(Reporting by Yadarisa Shabong in Bengaluru; Editing by Edmund Blair)
